Business ❯Healthcare

Pharmaceuticals

Pharmaceuticals Stock Market Pharmaceuticals Earnings Reports Market Trends Investment Market Analysis Corporate Finance Investments Stock Performance

Sanofi to Acquire Vigil Neuroscience in $600M Deal to Advance Alzheimer’s Research

The acquisition includes VG-3927, a Phase 2-ready TREM2 agonist, with a focus on microglial neuroprotection in Alzheimer’s disease.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Novo Nordisk CEO Steps Down Following Share Price Collapse

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Hims & Hers Reports Record Q1 Results While Stock Dips on Cautious Q2 Guidance

Moderna Reports Narrower Q1 Loss, Updates Cost-Cutting and Regulatory Timelines

CVS Health Beats Q1 Expectations and Raises 2025 Earnings Guidance

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

GSK Reports Strong Q1 Results, Confirms Readiness for Potential US Pharma Tariffs

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Merck KGaA Confirms $3.9 Billion Acquisition of SpringWorks Therapeutics

AbbVie Raises 2025 Profit Forecast Following Strong Q1 Growth in Immunology Drugs

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Walgreens Reaches $300 Million Settlement Over Invalid Opioid Prescriptions

Johnson & Johnson Exceeds Q1 Estimates, Boosts Revenue Forecast

Indian Pharmaceuticals Exempt from Trump's Tariffs, Boosting Stock Market Confidence

Hims & Hers Expands Weight-Loss Offerings with New Medications

Novo Holdings Reports Record Income Despite Novo Nordisk's Market Decline

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery